Literature DB >> 27259738

Analysis of Mitochondrial Control Region Using Sanger Sequencing.

David Ballard1.   

Abstract

The analysis of mitochondrial DNA (mtDNA) is an established forensic tool and has been used extensively to aid with both the identification of human remains and evidence recovered from scenes of crime. The biology of mtDNA confers both advantages and disadvantages when using it as a tool for identification. It benefits from a high copy number, which facilitates analysis from samples with highly degraded DNA or trace amounts of DNA, but the maternal mode of inheritance restricts its power of discrimination. With Next Generation Sequencing being used in research and some forensic casework laboratories the scope of mtDNA analysis in forensic casework may expand in the near future. Currently, however, most casework laboratories rely on Sanger sequencing and an established method for analyzing the hypervariable sequence regions is described.

Entities:  

Keywords:  Hypervariable sequence region I (HVS-I); Hypervariable sequence region II (HVS-II); Hypervariable sequence region III (HVS-III); Mitochondrial DNA

Mesh:

Substances:

Year:  2016        PMID: 27259738     DOI: 10.1007/978-1-4939-3597-0_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Massively parallel sequencing of human skeletal remains in Vietnam using the precision ID mtDNA control region panel on the Ion S5™ system.

Authors:  May Thi Anh Ta; Nam Ngoc Nguyen; Duc Minh Tran; Trang Hong Nguyen; Tuan Anh Vu; Dung Thi Le; Phuong Thi Le; Thu Thi Hong Do; Ha Hoang; Hoang Ha Chu
Journal:  Int J Legal Med       Date:  2021-07-01       Impact factor: 2.686

2.  Mitochondrial DNA in human identification: a review.

Authors:  António Amorim; Teresa Fernandes; Nuno Taveira
Journal:  PeerJ       Date:  2019-08-13       Impact factor: 2.984

3.  Ion torrent high throughput mitochondrial genome sequencing (HTMGS).

Authors:  N R Harvey; C L Albury; S Stuart; M C Benton; D A Eccles; J R Connell; H G Sutherland; R J N Allcock; R A Lea; L M Haupt; L R Griffiths
Journal:  PLoS One       Date:  2019-11-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.